摘要:
Objective To investigate the effect of bcl-XL antisense oligonucleotide transfection on the proliferation of colon cancer cells and the growth of human colon cancer xenografts in nude mice.Methods A long-term SW620 single cell suspension was prepared for subcutaneous injection in nude mice.Nude mice were randomly divided into 3 groups: control group,N-ODN group and antisense oligonucleotide group (n=5),with an average of 50 mm3.The antisense oligonucleotide group and N-ODN group were injected with 2 ml/kg antisense oligonucleotide or N-ODN,and the control group was injected with equal amount of normal saline.At 16th day after the operation,the tumor cells were taken out,and some tumor tissues were extracted.RNA and protein were extracted.The cationic liposome mediated transfection of antisense oligonucleotide,real-time quantitative polymerase chain reaction (Real-time PCR),Western blotting,methyl thiazol tetrazolium (MTT) method and TdT-mediated dUTP nick end labeling (TUNEL) method were applied to observe the effects of bcl-XL antisense oligonucleotide on the proliferation and apoptosis of colorectal cancer cells in vivo and the growth of human colon cancer xenografts.Results (1) The inhibition rate of cell proliferation activity was gradually increased with the increase of antisense oligonucleotide concentration.When the concentration was over 200 nmol/L,the inhibition rate of cell proliferation was significantly decreased with the difference being statistically significant (t=2.418,1.531 and 1.838,P=0.003,0.016 and 0.011).(2) The relative expression levels in the control group,blank control group,N-ODN group and mRNA antisense oligonucleotides group were 0.96±0.25,0.97±0.48,0.78±0.32 and 0.41±0.13,the inhibition rate was 0.00%,-6.25%,18.75% and 57.29%,respectively.There was significant difference between antisense oligonucleotide group and control group,blank control group or N-ODN group (P=0.025).(3) Compared with the control group,there was no significant change in the blank control group;the N-ODN group was slightly lower than that in the control group;the antisense oligonucleotide group was significantly lower (P=0.017).(4) The positive rates of cells in control group,blank control group,N-ODN group and antisense oligonucleotide group were 3.7%,5.0%,7.0% and 35.0%,respectively.By statistical analysis,antisense oligonucleotide group and cell control group,blank control group and N-ODN group,the difference was statistically significant (χ2=181.880,P=0.000);cells in the control group,N-ODN group and control group comparison between 22 blank,there was no statistically significant difference (χ2=1.410,P=0.084).(5) There was no significant difference in tumor volume between first groups (P=0.162).On the sixth day,there was significant difference between the antisense oligonucleotide group and the control group (t=2.410,P=0.027).On the eleventh and the 16 day,there was significant difference between the two groups in (P=0.028,0.016).(6) The expression of bcl-XL gene in the tumor tissues of the 3 groups of nude mice was significantly decreased after antisense oligonucleotide treatment,but the expression of antisense oligonucleotide group was significantly decreased,while the expression of N-ODN in the control group and the control group did not change significantly.Conclusion bcl-XL antisense oligonucleotides can effectively inhibit the proliferation of colon cancer cells and the growth of human colon cancer xenografts in nude mice.To reduce the expression of bcl-XL by antisense oligonucleotides,and to provide the experimental basis for gene therapy of colon cancer.%目的 观察bcl-XL反义寡核苷酸转染后,对结肠癌细胞增殖及裸鼠体内人结肠癌移植瘤生长的影响.方法 制备对数生长期的SW620单细胞悬液,裸鼠背侧皮下注射.当移植瘤体积平均50mm时,将裸鼠随机分为3组:对照组、N-ODN组和反义寡核苷酸组,每组5只.反义寡核苷酸组及N-ODN组瘤旁注射2ml/kg体重的反义寡核苷酸或N-ODN,对照组瘤旁注射等量生理盐水,第16天处死裸鼠,取部分肿瘤组织,提取RNA及蛋白,采用阳离子脂质体介导的反义寡核苷酸转染、实时定量聚合酶链反应(Real-time PCR)、Western blot、噻唑蓝(MTT)法、原位缺口末端标记法(TUNEL)等方法观察了bcl-XL反义寡核苷酸转染对结肠癌细胞增殖、凋亡的影响及裸鼠体内人结肠癌移植瘤生长的影响.结果 (1)对细胞增殖活性的抑制率随反义寡核苷酸浓度的增加逐渐增高,具剂量依赖性.当浓度超过200nμmol/L后,对细胞活性的增殖抑制率递增幅度明显减小,差异有统计学意义(t=2.418、1.531和1.838,P=0.003、0.016和0.011).(2)细胞对照组、空白对照组、N-ODN组及反义寡核苷酸组的mRNA相对表达量分别为0.96±0.25、0.97±0.48、0.78±0.32及0.41±0.13,抑制率分别为0.00%、-6.25%、18.75%及57.29%,与细胞对照组比较,除空白对照组有少量增高外,N-ODN组及反义寡核苷酸组的表达依次减弱,抑制率依次增加.反义寡核苷酸组与细胞对照组、空白对照组及N-ODN组比较,差异有统计学意义(P=0.025);N-ODN组、空白对照组及细胞对照组间两两比较,差异无统计学意义(P=0.263).(3)与细胞对照组比较,空白对照组无明显变化;N-ODN组稍有降低;反义寡核苷酸组明显降低(P=0.017).(4)细胞对照组、空白对照组、N-ODN组及反义寡核苷酸组的阳性细胞的阳性率分别为3.7%、5.0%、7.0%及35.0%.经统计学分析,反义寡核苷酸组与细胞对照组、空白对照组及N-ODN组比较,差异有统计学意义(χ2=181.880,P=0.000);细胞对照组、空白对照组及N-ODN组间两两比较,差异无统计学意义(χ2=1.410,P=0.084).(5)治疗第1天,肿瘤体积各组间差异无统计学意义(P=0.162).第6天,反义寡核苷酸组与对照组比较差异有统计学意义(t=2.410,P=0.027).第11、16天,各组两两比较差异均有统计学意义(P=0.028、0.016).(6)反义寡核甘酸体内治疗后,3组裸鼠肿瘤组织中均有bcl-XL基因的表达,但反义寡核甘酸组的表达明显减弱,而对照组及N-ODN组的表达未发生明显改变.结论 bcl-XL反义寡核苷酸可有效抑制结肠癌细胞增殖及裸鼠体内人结肠癌移植瘤的生长.通过反义寡核苷酸下调bcl-XL的表达,可治疗结肠癌.